QURE News
-
QURE bullish
QURE Looks 474.5% Overvalued on GF Value™
gurufocus.com·Sep 2, 2026·On September 02, 2026, uniQure NV (NASDAQ: QURE) announced it has submitted a marketing application to the FDA seeking accelerated approval for its gene therapy...
-
QURE neutral
Abrdn Life Sciences Investors Q2 2026 Commentary (HQL)
seekingalpha.com·Aug 30, 2026·Rasi Bhadramani/iStock via Getty Images Fund performance The equity portion of the Fund rose (gross of fees) and outperformed its benchmark, the NASDAQ Biotec...
-
QURE neutral
abrdn Life Sciences Investors Q2 2026 Commentary
seekingalpha.com·Aug 13, 2026·Benjamas Deekam/iStock via Getty Images Fund performance The equity portion of the Fund rose (gross of fees) and outperformed its benchmark, the NASDAQ Biotec...
-
QURE bullish
5 Biotech Stocks That Delivered Big Gains - Key Catalysts Ahead For QURE, CDNA, ADPT, ELVN & AMLX
rttnews.com·Aug 2, 2026·As Warren Buffett once said, "If you find three wonderful businesses in your life, you'll get very rich." His message underscores the importance of identifying ...
-
QURE neutral
uniQure: 'Hold' AMT-130 U-Turn By FDA For HD Could Possibly Alter Course (NASDAQ:QURE)
seekingalpha.com·Jul 31, 2026·This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you ...